DE60334220D1 - Rationell konstruierte, von chondroitinase b abgeleitete lyasen - Google Patents
Rationell konstruierte, von chondroitinase b abgeleitete lyasenInfo
- Publication number
- DE60334220D1 DE60334220D1 DE60334220T DE60334220T DE60334220D1 DE 60334220 D1 DE60334220 D1 DE 60334220D1 DE 60334220 T DE60334220 T DE 60334220T DE 60334220 T DE60334220 T DE 60334220T DE 60334220 D1 DE60334220 D1 DE 60334220D1
- Authority
- DE
- Germany
- Prior art keywords
- chondroitinase
- inhibiting
- rationally constructed
- relates
- lyases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0069—Chondroitin-4-sulfate, i.e. chondroitin sulfate A; Dermatan sulfate, i.e. chondroitin sulfate B or beta-heparin; Chondroitin-6-sulfate, i.e. chondroitin sulfate C; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/527—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving lyase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US38550902P | 2002-06-03 | 2002-06-03 | |
PCT/US2003/017680 WO2003102160A2 (en) | 2002-06-03 | 2003-06-03 | Rationally designed polysaccharide lyases derived from chondroitinase b |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60334220D1 true DE60334220D1 (de) | 2010-10-28 |
Family
ID=29712183
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60334220T Expired - Lifetime DE60334220D1 (de) | 2002-06-03 | 2003-06-03 | Rationell konstruierte, von chondroitinase b abgeleitete lyasen |
Country Status (7)
Country | Link |
---|---|
US (4) | US6962699B2 (de) |
EP (1) | EP1532241B1 (de) |
AT (1) | ATE481478T1 (de) |
AU (1) | AU2003243396A1 (de) |
CA (1) | CA2493509C (de) |
DE (1) | DE60334220D1 (de) |
WO (1) | WO2003102160A2 (de) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000012726A2 (en) * | 1998-08-27 | 2000-03-09 | Massachusetts Institute Of Technology | Rationally designed heparinases derived from heparinase i and ii |
EP1137373A4 (de) * | 1998-12-04 | 2004-05-19 | Chandrashekhar P Pathak | Biokompatible, vernetzte polymere |
US6597996B1 (en) * | 1999-04-23 | 2003-07-22 | Massachusetts Institute Of Technology | Method for indentifying or characterizing properties of polymeric units |
US6869789B2 (en) | 2000-03-08 | 2005-03-22 | Massachusetts Institute Of Technology | Heparinase III and uses thereof |
JP4911865B2 (ja) * | 2000-09-12 | 2012-04-04 | マサチューセッツ インスティテュート オブ テクノロジー | 低分子量ヘパリンに関連する方法および生成物 |
WO2002032406A2 (en) | 2000-10-18 | 2002-04-25 | Massachusetts Institute Of Technology | Methods and products related to pulmonary delivery of polysaccharides |
CA2484604C (en) | 2002-05-03 | 2011-08-02 | Massachusetts Institute Of Technology | .delta. 4,5 glycuronidase and uses thereof |
EP2301564A1 (de) | 2002-05-04 | 2011-03-30 | Acorda Therapeutics, Inc. | Zusammensetzungen und verfahren zur förderung des neuronalen wachstums |
EP1590648A4 (de) * | 2002-05-20 | 2007-04-18 | Massachusetts Inst Technology | Neues verfahren zur sequenzbestimmung mittels nmr |
AU2003243396A1 (en) * | 2002-06-03 | 2003-12-19 | Massachusetts Institute Of Technology | Rationally designed polysaccharide lyases derived from chondroitinase b |
AU2003265561A1 (en) * | 2002-08-15 | 2004-03-03 | Acorda Therapeutics, Inc. | Chimeric protein |
JP4606712B2 (ja) * | 2003-01-08 | 2011-01-05 | マサチューセッツ インスティテュート オブ テクノロジー | 2−oスルファターゼ組成物および関連の方法 |
AU2016204464B2 (en) * | 2003-05-16 | 2018-03-22 | Acorda Therapeutics, Inc. | Proteoglycan degrading mutants for treatment of cns |
MX348062B (es) | 2003-05-16 | 2017-05-26 | Acorda Therapeutics Inc | Mutantes que degradan proteoglicanos para tratamiento del snc. |
ES2420510T3 (es) * | 2003-05-16 | 2013-08-23 | Acorda Therapeutics, Inc. | Composiciones y métodos para el tratamiento de lesiones del SNC |
US7959914B2 (en) | 2003-05-16 | 2011-06-14 | Acorda Therapeutics, Inc. | Methods of reducing extravasation of inflammatory cells |
US20070161599A1 (en) * | 2003-05-28 | 2007-07-12 | The Board Of Trustees Of The University Of Illinois | Composition for blocking hiv binding to dendritic cells and methods of use thereof |
CA2558984A1 (en) * | 2004-03-10 | 2005-09-22 | Massachusetts Institute Of Technology | Recombinant chondroitinase abc i and uses thereof |
WO2005110438A2 (en) * | 2004-04-15 | 2005-11-24 | Massachusetts Institute Of Technology | Methods and products related to the intracellular delivery of polysaccharides |
US20060127950A1 (en) * | 2004-04-15 | 2006-06-15 | Massachusetts Institute Of Technology | Methods and products related to the improved analysis of carbohydrates |
US20060057638A1 (en) * | 2004-04-15 | 2006-03-16 | Massachusetts Institute Of Technology | Methods and products related to the improved analysis of carbohydrates |
ES2411504T3 (es) | 2004-05-18 | 2013-07-05 | Acorda Therapeutics, Inc. | Métodos de purificación de condroitinasa y formulaciones estables de la misma |
CA2614068A1 (en) | 2004-06-29 | 2006-08-24 | Massachusetts Institute Of Technology | Methods and compositions related to the modulation of intercellular junctions |
US20060154894A1 (en) * | 2004-09-15 | 2006-07-13 | Massachusetts Institute Of Technology | Biologically active surfaces and methods of their use |
JP5189985B2 (ja) | 2005-09-26 | 2013-04-24 | アコーダ セラピューティクス、インク. | コンドロイチナーゼabci変異体を用いた組成物およびその使用方法 |
WO2007120478A2 (en) * | 2006-04-03 | 2007-10-25 | Massachusetts Institute Of Technology | Glycomic patterns for the detection of disease |
WO2008045970A2 (en) | 2006-10-10 | 2008-04-17 | Acorda Therapeutics, Inc. | Compositions and methods of using chondroitinase abci mutants |
WO2008085912A1 (en) | 2007-01-05 | 2008-07-17 | Massachusetts Institute Of Technology | Compositions of and methods of using sulfatases from flavobacterium heparinum |
EP2150616A4 (de) | 2007-05-10 | 2011-07-27 | Univ Arizona | Geregelte antigensynthese und/oder geregelte attenuation zur verbesserung der impfstoff immunogenität und/oder -sicherheit |
GB0712302D0 (en) * | 2007-06-22 | 2007-08-01 | Cambridge Entpr Ltd | Chrondroitinase polypeptides |
US20090286289A1 (en) * | 2008-03-10 | 2009-11-19 | Pang Danny Z | Production of Hyaluronate Unsaturated Disaccharides and its Application |
US9045742B2 (en) * | 2009-05-29 | 2015-06-02 | The Arizona Board Of Regents For And On Behalf Of Arizona State University | Recombinant Edwardsiella bacterium |
US9796970B1 (en) | 2017-04-24 | 2017-10-24 | Advantek Serum Laboratories Ltd. | Production of high purity chondroitinase ABC |
CN111593040B (zh) * | 2020-06-20 | 2022-08-30 | 山东大学 | 硫酸皮肤素裂解酶及其应用 |
Family Cites Families (75)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US37376A (en) * | 1863-01-06 | Improvement in breech-loading fire-arms | ||
US91471A (en) * | 1869-06-15 | steigmeyer | ||
US128225A (en) * | 1872-06-25 | Improvement in workmen s time-registers | ||
US8820A (en) * | 1852-03-23 | Improvement in friction-primers for cannon | ||
US204869A (en) * | 1878-06-11 | Improvement in weighing-scales | ||
US91472A (en) * | 1869-06-15 | Improvement in plows | ||
US99628A (en) * | 1870-02-08 | Signors to themselves and a | ||
US169143A (en) * | 1875-10-26 | Improvement in perforating stamps | ||
US122793A (en) * | 1872-01-16 | Improvement in air-supplying attachments for stoves | ||
US92037A (en) * | 1869-06-29 | Improved shoe-pegging- machine | ||
US197933A (en) * | 1877-12-11 | Improvement in wood-screws | ||
US191587A (en) * | 1877-06-05 | Improvement in piano-forte bridges | ||
JPS6031478B2 (ja) | 1978-02-10 | 1985-07-22 | 生化学工業株式会社 | 純コンドロイチナ−ゼbの製造法 |
US4341869A (en) * | 1980-08-25 | 1982-07-27 | Massachusetts Institute Of Technology | Process for producing heparinase |
US5169772A (en) | 1988-06-06 | 1992-12-08 | Massachusetts Institute Of Technology | Large scale method for purification of high purity heparinase from flavobacterium heparinum |
JP2726275B2 (ja) | 1988-08-24 | 1998-03-11 | 生化学工業株式会社 | グリコサミノグリカン分解酵素の精製法 |
JPH0693836B2 (ja) | 1988-11-25 | 1994-11-24 | 新技術事業団 | バチルス属に属するヘパリナーゼ生産微生物、新規ヘパリナーゼ及びその製法 |
ZA912770B (en) | 1990-04-16 | 1992-01-29 | Bethesda Eye Inst | Enzymatic disinsertion of vitreous body |
JPH04270327A (ja) * | 1991-02-26 | 1992-09-25 | Fuji Photo Optical Co Ltd | カメラの露出補正装置 |
JP3110064B2 (ja) | 1991-03-06 | 2000-11-20 | 生化学工業株式会社 | 新規ヘパリチナーゼ、その製造法及びその生産菌 |
US5262325A (en) | 1991-04-04 | 1993-11-16 | Ibex Technologies, Inc. | Method for the enzymatic neutralization of heparin |
US5668274A (en) | 1991-04-23 | 1997-09-16 | Akzo Nobel N.V. | Sulfated glycosaminoglycanoid derivatives of the dermatan sulfate and chondroitin sulfate type |
US5714376A (en) | 1991-10-23 | 1998-02-03 | Massachusetts Institute Of Technology | Heparinase gene from flavobacterium heparinum |
US6001630A (en) | 1992-06-26 | 1999-12-14 | Seikagaku Kogyo Kabushiki Kaisha (Seikagaku Corporation) | Pharmaceutical compositions of chondroitinase ABC isolated from Proteus vulgaris ATCC 6896 |
US5773277A (en) | 1992-06-26 | 1998-06-30 | Seikagaku Kogyo Kabushiki Kaisha | Crystalline chondroitinase isolated from Proteus vulgaris ATCC 6896 |
US5496718A (en) | 1992-06-26 | 1996-03-05 | Seikagaku Kogyo Kabushiki Kaisha (Seikagaku Corporation) | Chondroitinase ABC isolated from proteus vulgaris ATCC 6896 |
JP3419811B2 (ja) | 1993-02-24 | 2003-06-23 | マルハ株式会社 | コンドロイチナーゼ遺伝子 |
US5389539A (en) | 1992-11-30 | 1995-02-14 | Massachusetts Institute Of Technology | Purification of heparinase I, II, and III from Flavobacterium heparinum |
US5578480A (en) * | 1993-04-23 | 1996-11-26 | American Cyanamid Company | Methods for the isolation and purification of the recombinantly expressed chondroitinase I and II enzymes from P. vulgaris |
ATE211487T1 (de) | 1993-09-30 | 2002-01-15 | Seikagaku Kogyo Co Ltd | Dermatansulfatezusammensetzung als antithromotisches mittel |
WO1995013830A1 (en) * | 1993-11-17 | 1995-05-26 | Massachusetts Institute Of Technology | Method for inhibiting angiogenesis using heparinase |
US5525500A (en) | 1994-04-22 | 1996-06-11 | American Cyanamid Company | Chromatographic process for the copurification of chondroitinase I and II proteins from Proteus vulgaris |
CA2188159A1 (en) | 1994-04-22 | 1995-11-02 | Kiran Manohar Khandke | Chondroitinases i and ii, methods of preparation, and use thereof |
US5498536A (en) | 1994-04-22 | 1996-03-12 | American Cyanamid Company | Chondroitinase II from Proteus vulgaris |
US5681733A (en) * | 1994-06-10 | 1997-10-28 | Ibex Technologies | Nucleic acid sequences and expression systems for heparinase II and heparinase III derived from Flavobacterium heparinum |
US5619421A (en) * | 1994-06-17 | 1997-04-08 | Massachusetts Institute Of Technology | Computer-implemented process and computer system for estimating the three-dimensional shape of a ring-shaped molecule and of a portion of a molecule containing a ring-shaped structure |
US5997863A (en) | 1994-07-08 | 1999-12-07 | Ibex Technologies R And D, Inc. | Attenuation of wound healing processes |
US6093563A (en) | 1994-07-08 | 2000-07-25 | Ibex Technologies R And D, Inc. | Chondroitin lyase enzymes |
US5965507A (en) * | 1995-06-08 | 1999-10-12 | Procter & Gamble Company | Cleaning compositions comprising chondroitinase |
WO1997016556A1 (en) | 1995-10-30 | 1997-05-09 | Massachusetts Institute Of Technology | Rationally designed polysaccharide lyases derived from heparinase i |
US5866120A (en) | 1995-11-22 | 1999-02-02 | Advanced Corneal Systems, Inc. | Method for accelerating clearance of hemorrhagic blood from the vitreous humor with hyaluronidase |
IT1285546B1 (it) | 1996-01-16 | 1998-06-18 | Alfa Wassermann Spa | Uso del dermatano solfato a basso peso molecolare e delle specialita' medicinali che lo contengono nella terapia e nella prevenzione della |
EP0875253B1 (de) | 1997-05-02 | 2005-04-06 | Seikagaku Corporation | Chondroitinase enthaltende Zusammensetzungen |
US6063378A (en) * | 1997-08-22 | 2000-05-16 | Seikagaku Corporation | Therapeutic agent for herniated intervertebral disc |
US6190875B1 (en) | 1997-09-02 | 2001-02-20 | Insight Strategy & Marketing Ltd. | Method of screening for potential anti-metastatic and anti-inflammatory agents using mammalian heparanase as a probe |
US5968822A (en) | 1997-09-02 | 1999-10-19 | Pecker; Iris | Polynucleotide encoding a polypeptide having heparanase activity and expression of same in transduced cells |
US6378527B1 (en) | 1998-04-08 | 2002-04-30 | Chondros, Inc. | Cell-culture and polymer constructs |
AU3985499A (en) | 1998-05-13 | 1999-11-29 | Biomarin Pharmaceutical Inc. | Lytic enzymes useful for treating fungal infections |
JP2000044601A (ja) | 1998-07-29 | 2000-02-15 | Seikagaku Kogyo Co Ltd | 新規ガラクトサミノグリカン |
US6597996B1 (en) | 1999-04-23 | 2003-07-22 | Massachusetts Institute Of Technology | Method for indentifying or characterizing properties of polymeric units |
WO2001034781A2 (en) | 1999-11-12 | 2001-05-17 | Biomarin Pharmaceuticals | Lytic enzymes useful for treating fungal infections |
WO2001035977A2 (en) | 1999-11-17 | 2001-05-25 | Ibex Technologies, Inc. | Attenuation of tumor growth, metastasis and angiogenesis by use of chondroitin sulfate degrading enzymes |
WO2001038399A1 (fr) | 1999-11-24 | 2001-05-31 | Seikagaku Corporation | Procede de traitement des maladies des tissus superficiels |
CA2393186A1 (en) | 1999-12-02 | 2001-06-07 | Ibex Technologies, Inc. | Attenuation of fibroblast proliferation |
JP2003520598A (ja) | 2000-01-21 | 2003-07-08 | アイベックス ファーマシューティカルズ インコーポレイティッド | フラボバクテリウム・ヘパリナム発現系 |
US6869789B2 (en) | 2000-03-08 | 2005-03-22 | Massachusetts Institute Of Technology | Heparinase III and uses thereof |
JP4911865B2 (ja) * | 2000-09-12 | 2012-04-04 | マサチューセッツ インスティテュート オブ テクノロジー | 低分子量ヘパリンに関連する方法および生成物 |
WO2002032406A2 (en) | 2000-10-18 | 2002-04-25 | Massachusetts Institute Of Technology | Methods and products related to pulmonary delivery of polysaccharides |
CA2441986A1 (en) | 2001-03-27 | 2002-10-03 | Massachusetts Institute Of Technology | Methods and products related to fgf dimerization |
CA2459040A1 (en) | 2001-09-14 | 2003-03-27 | Mimeon, Inc. | Methods of making glycolmolecules with enhanced activities and uses thereof |
US20040214228A9 (en) * | 2001-09-14 | 2004-10-28 | Ganesh Venkataraman | Methods of evaluating glycomolecules for enhanced activities |
GB0205022D0 (en) | 2002-03-04 | 2002-04-17 | Univ Cambridge Tech | Materials and methods for the treatment of cns damage |
AU2003225724A1 (en) | 2002-03-11 | 2003-09-29 | Momenta Pharmaceuticals, Inc. | Analysis of sulfated polysaccharides |
CA2483271A1 (en) * | 2002-04-25 | 2003-11-06 | Momenta Pharmaceuticals, Inc. | Methods and products for mucosal delivery |
CA2484604C (en) * | 2002-05-03 | 2011-08-02 | Massachusetts Institute Of Technology | .delta. 4,5 glycuronidase and uses thereof |
EP1590648A4 (de) | 2002-05-20 | 2007-04-18 | Massachusetts Inst Technology | Neues verfahren zur sequenzbestimmung mittels nmr |
AU2003243396A1 (en) | 2002-06-03 | 2003-12-19 | Massachusetts Institute Of Technology | Rationally designed polysaccharide lyases derived from chondroitinase b |
US20040147033A1 (en) * | 2002-12-20 | 2004-07-29 | Zachary Shriver | Glycan markers for diagnosing and monitoring disease |
JP4606712B2 (ja) | 2003-01-08 | 2011-01-05 | マサチューセッツ インスティテュート オブ テクノロジー | 2−oスルファターゼ組成物および関連の方法 |
KR100846449B1 (ko) * | 2003-03-27 | 2008-07-16 | 삼성전자주식회사 | 휴대용 복합장치의 웹 카메라 모드 설정방법 |
MX348062B (es) | 2003-05-16 | 2017-05-26 | Acorda Therapeutics Inc | Mutantes que degradan proteoglicanos para tratamiento del snc. |
US7407810B2 (en) | 2003-09-04 | 2008-08-05 | Momenta Pharmaceuticals, Inc. | Methods and apparatus for characterizing polymeric mixtures |
US7851223B2 (en) * | 2004-02-27 | 2010-12-14 | Roar Holding Llc | Method to detect emphysema |
AU2005219413A1 (en) | 2004-03-02 | 2005-09-15 | Massachusetts Institute Of Technology | Nanocell drug delivery system |
ES2411504T3 (es) | 2004-05-18 | 2013-07-05 | Acorda Therapeutics, Inc. | Métodos de purificación de condroitinasa y formulaciones estables de la misma |
-
2003
- 2003-06-03 AU AU2003243396A patent/AU2003243396A1/en not_active Abandoned
- 2003-06-03 DE DE60334220T patent/DE60334220D1/de not_active Expired - Lifetime
- 2003-06-03 US US10/454,816 patent/US6962699B2/en not_active Expired - Lifetime
- 2003-06-03 EP EP03756399A patent/EP1532241B1/de not_active Expired - Lifetime
- 2003-06-03 CA CA002493509A patent/CA2493509C/en not_active Expired - Fee Related
- 2003-06-03 AT AT03756399T patent/ATE481478T1/de not_active IP Right Cessation
- 2003-06-03 WO PCT/US2003/017680 patent/WO2003102160A2/en not_active Application Discontinuation
-
2004
- 2004-10-14 US US10/967,041 patent/US7105334B2/en not_active Expired - Lifetime
- 2004-10-14 US US10/966,671 patent/US7129335B2/en not_active Expired - Lifetime
-
2006
- 2006-09-08 US US11/518,389 patent/US20070065424A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
ATE481478T1 (de) | 2010-10-15 |
AU2003243396A8 (en) | 2003-12-19 |
US7129335B2 (en) | 2006-10-31 |
US7105334B2 (en) | 2006-09-12 |
WO2003102160A2 (en) | 2003-12-11 |
EP1532241A4 (de) | 2005-12-14 |
CA2493509A1 (en) | 2003-12-11 |
EP1532241A2 (de) | 2005-05-25 |
US20050233419A1 (en) | 2005-10-20 |
US20040091472A1 (en) | 2004-05-13 |
US6962699B2 (en) | 2005-11-08 |
US20050227320A1 (en) | 2005-10-13 |
WO2003102160A3 (en) | 2004-09-16 |
US20070065424A1 (en) | 2007-03-22 |
EP1532241B1 (de) | 2010-09-15 |
AU2003243396A1 (en) | 2003-12-19 |
CA2493509C (en) | 2010-03-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60334220D1 (de) | Rationell konstruierte, von chondroitinase b abgeleitete lyasen | |
Pereira et al. | Structure and anticoagulant activity of a sulfated galactan from the red alga, Gelidium crinale. Is there a specific structural requirement for the anticoagulant action? | |
Melo et al. | Antithrombin-mediated anticoagulant activity of sulfated polysaccharides: different mechanisms for heparin and sulfated galactans | |
DK1319183T3 (da) | Fremgangsmåder og produkter relateret til heparin med lav molekylvægt | |
WO2005087920A3 (en) | Recombinant chondroitinase abc i and uses thereof | |
ATE490786T1 (de) | Behandlung von verletzungen des zentralen nervensystems | |
NO20070551L (no) | Vaksinesammensetninger og fremgangsmater for behandling av koronavirus infeksjon. | |
ATE464722T1 (de) | Adaptives filtersystem für reklamenachrichten | |
EA200900741A1 (ru) | Способы лечения гиперхолестеринемии | |
ATE277157T1 (de) | Reinigungsverfahren zur stärkeentfernung | |
ITBO20020620A1 (it) | Condotto multi-canale bioriassorbibile di rigenerazione del nervo e processo per preparare il medesimo. | |
NO20000752L (no) | Metode for forhindring eller behandling av østrogen-avhengige sykdommer og forstyrrelser | |
BRPI0409655A (pt) | compostos heterocìclicos de ligação ao receptor para quimiocina com maior eficiência | |
DK0897393T3 (da) | Derivater af K5-polysaccharid med antikoagulerende aktivitet | |
HK1044115A1 (en) | Immunoadsorber for use in sepsis therapy | |
SE9904581D0 (sv) | A novel helicobacter pylori-binding substance and use thereof | |
DK1165112T3 (da) | Modulatorer af polysaccharider og anvendelser deraf | |
BR9911785A (pt) | Combinações de farnesil transferase de proteìna e inibidores de redutase de hmg coa e seu uso para tratar câncer | |
DE60331254D1 (de) | Nahrungsmittelverarbeitung mittels schockwellen | |
AR021692A1 (es) | Tiorredoxina y procesamiento de granos | |
ITMI20030661A1 (it) | Processo per la preparazione della ferutinina da piante del genere ferula | |
DE60039437D1 (de) | Verwendung der sulfatierten polysacchariden zur behandlung von thrombosen | |
ATE392212T1 (de) | Verwendung eines proteasom-inhibitors zur behandlung fibrotischer erkrankungen | |
DK1658494T3 (da) | Fremgangsmåde til en in vitro titrering af en NCTA og anvendelse deraf i en fremgangsmåde til evalueringen og/eller monitorering af en biologisk produktproduktionsfremgangsmåde | |
WO2009137899A3 (en) | Sulfated galactans with antithrombotic activity, pharmaceutical composition, method for treating or prophylaxis of arterial or venous thrombosis, method of extraction and use thereof |